Pulmonary Fibrosis
Conditions
Keywords
Pulmonary Fibrosis
Brief summary
Taking part in clinical trials usually favors a particular demographic group. But there is limited research available to explain what research attributes affect the completion of these specific demographic groups. This study will admit a wide range of data on the clinical trial experience of pulmonary fibrosis patients to determine which factors prevail in limiting a patient's ability to join or finish a trial. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future pulmonary fibrosis patients.
Interventions
None listed
Sponsors
Power Life Sciences Inc.
Study design
Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patient is at least 18 years of age * Diagnosis of pulmonary fibrosis * Ability to understand the study procedures, benefits and risks, and sign a written informed consent document.
Exclusion criteria
* Enrolled in another research study * Inability to provide written informed consent * Women of childbearing potential without a negative pregnancy test; or women who are lactating.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of pulmonary fibrosis patients who decide to participate in a clinical study | 3 months |
| Rate of patients who remain in an pulmonary fibrosis clinical study to completion | 12 months |
Countries
United States
Contacts
Primary ContactMichael B Gill
Outcome results
None listed